logo
'I want my sister to live': Local fashion label The Closet Lover to shut amid co-founder's health scare

'I want my sister to live': Local fashion label The Closet Lover to shut amid co-founder's health scare

New Paper03-05-2025

Local fashion label The Closet Lover (TCL) will be shuttering after 17 years due to the deteriorating health of owner Brianna Wong, but her co-founder sister is not ruling out a comeback.
Ms Bertilla Wong, 35, told The Straits Times on May 3 that her sister's health took a turn for the worse in February during her two-week visit in South Korea.
"She experienced very high blood pressure. Her legs and limbs were extremely swollen and she even had difficulty breathing at times such that she had to visit the doctor twice while she was in Seoul," said Ms Wong.
Ms Brianna Wong, 39, who was previously diagnosed with systemic lupus erythematosus, commonly referred to as lupus, was warded the moment she returned to Singapore.
Lupus is an autoimmune condition where the body's immune system attacks the healthy tissues and organs.
The Lupus Foundation of America estimates that at least five million people worldwide have a form of lupus, and women make up the majority of such patients. Scientists suspect that sex hormones play a part.
Symptoms associated with the condition include joint pain, fatigue and a butterfly rash that appears across the cheeks and nose.
Ms Bertilla Wong said the doctor informed her older sister that her kidney and heart were inflamed due to the stress she was facing and advised her to prioritise her health.
"When I heard that, I was very worried and persuaded her to end the business first to recuperate because I want my sister to live," said Ms Bertilla Wong.
TCL, which started as an online blogshop in 2007, will close its doors on June 15. Until then, the fashion label, which has 137,000 followers on Instagram and 13,400 followers on TikTok, will continue with its weekly livestreams and launches.
The brand's final act before bowing out will be on May 25: the launch of a collaboration with an international brand that Ms Bertilla Wong declines to reveal more about.
Fortunately for Ms Wong, who was also diagnosed with the same condition as her older sister, she is in a much better place today.
"My last flare-up was many years ago. I get joint pain occasionally when I'm stressed out but other than that, my organs are intact and fine," she said, adding that she has been helming the business for the last few months while her sister recuperates.
When asked if she had thought of selling the fashion brand, Ms Wong said they considered that option but eventually decided against it.
She explained that the brand and sales are tied to the two of them, and there "is no point" if they have to continue to help out after selling.
"The priority for us right now is to rest and recuperate from the stress of running the business and not think of anything else," said Ms Wong.
Besides her older sister's condition, Ms Wong acknowledges that it has not been an easy journey running TCL, whose annual revenue she says is under $10 million, in the post-Covid times.
At one point, the company owned four retail outlets in Singapore. Overseas, it operated two stores in Malaysia and had two franchise stores in Cambodia before they closed down in 2021 and 2024, respectively.
There are currently three TCL outlets in Bugis, Orchard and Tampines.
TCL, which started as an online blogshop in 2007, will close its doors on June 15. PHOTO: COURTESY OF BERTILLA WONG
Noting that consumers' tastes and preferences have evolved after the pandemic, Ms Wong said people were thinking twice about spending money on clothes. This drove her company to put in more effort to woo customers on social media and conduct regular livestreams to promote its products.
"It was very tiring for myself, my older sister and my employees. The situation got really bad during the recent Chinese New Year launches where we livestreamed six days a week to showcase our new products," she said.
"We also had to cut some of our retail leases previously as well so there were definitely some financial losses; but ultimately, even if the business was doing super well, we wouldn't have been able to keep it going if we were to run it at the expense of our health."
On their future plans, Ms Wong said she will continue to livestream for TikTok as well as promote health and wellness products for a local brand on social media, while her sister continues to recuperate.
The brand's final act before bowing out will be on May 25: the launch of a collaboration with an international brand that Ms Bertilla Wong declines to reveal more about. PHOTO: COURTESY OF BERTILLA WONG
But she does not rule out a comeback for TCL in the future.
"My sister is still very interested in fashion and when she gets better, she may still come up with something on a smaller scale, something more manageable that will not affect her health," said Ms Wong, adding that her older sister will still appear on her TikTok livestreams from time to time.
Beyond that, Ms Wong said she and her sister are extremely grateful to the people they have met - suppliers, friends, collaborators and customers - since they embarked on this enterprise.
"We are thankful for their support all these years and especially so for our employees, who have been very understanding about the situation as we try to help them to transit smoothly during this difficult period."

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Kennedy's new vaccine adviser was expert witness against Merck vaccine
Kennedy's new vaccine adviser was expert witness against Merck vaccine

Straits Times

timea day ago

  • Straits Times

Kennedy's new vaccine adviser was expert witness against Merck vaccine

FILE PHOTO: U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. attends a Senate Health, Education, Labor & Pensions Committee hearing on the Department of Health and Human Services budget, on Capitol Hill in Washington, D.C., U.S., May 14, 2025. REUTERS/Leah Millis One of the new vaccine advisers picked by U.S. Health Secretary Robert F. Kennedy Jr. has earned thousands of dollars as an expert witness in litigation against Merck's Gardasil vaccine, court records show. Martin Kulldorff, a biostatistician and epidemiologist who publicly criticized COVID-era lockdowns, is one of eight new members named by Kennedy on Wednesday to the Advisory Committee on Immunization Practices, a highly influential panel that recommends which shots should be administered to the American public. Kennedy fired the entire previous 17-member committee of expert vaccine advisers this week, claiming they were "plagued with persistent conflicts of interest" from financial ties to drugmakers. The departing experts say their work was subjected to rigorous vetting and rules for recusal for any conflict. Kulldorff recently served as an expert witness for plaintiffs who accused Merck of concealing the risks of Gardasil, a vaccine for the prevention of cancers caused by human papillomavirus (HPV). In March, a federal judge in North Carolina ruled in favor of Merck in one of those cases that included about 200 lawsuits. At a deposition in October, Kulldorff testified that the plaintiffs paid him $400 an hour and he had already billed for about $33,000 in legal work on the case through late September. He said he also received a $4,000 retainer in the North Carolina case, according to court documents. Kulldorff is also listed as an expert witness in a similar case pending against Merck in Los Angeles state court, records show. Under ACIP's rules, committee members cannot serve as a "paid litigation consultant or expert witness in litigation involving a vaccine manufacturer" during their tenure on the panel. Prior work as an expert witness against drugmakers may require a waiver from the U.S. Centers for Disease Control and Prevention and recusal from votes involving Merck and HPV vaccines. The agency has said in its rules it "will generally consider issuance of waivers in specific situations." Kulldorff and plaintiffs lawyers in the Merck case did not immediately respond to a request for comment. Merck declined to comment. A spokesman for Kennedy's Health and Human Services Department said on Wednesday that "all newly appointed ACIP members were thoroughly vetted." HHS did not immediately respond to a request for comment on Kulldorff. KENNEDY AND GARDASIL Before joining the Trump administration, Kennedy was a longtime plaintiffs' lawyer and played an instrumental role in organizing mass litigation against Merck over its Gardasil vaccine, which brought in sales of $8.58 billion in 2024. The shot is recommended as a routine immunization for 11 and 12-year-olds by the CDC to prevent cervical and certain head and neck cancers caused by the virus. Kennedy's work on the Gardasil case drew attention from Congress during the confirmation process for health secretary. Kennedy said he would divest his financial interest in that litigation to his non-dependent, adult son. In a post on X, Kennedy praised Kulldorff as a "leading expert in vaccine safety and infectious disease surveillance." He also cited his previous service as a government adviser, including on a vaccine safety subgroup assisting the full ACIP board. Kulldorff gained prominence during the COVID-19 pandemic as a co-author of the Great Barrington Declaration in October 2020, which called on public health officials to roll back lockdowns, arguing they were causing irreparable harm. One of his co-authors was Dr. Jay Bhattacharya, who now serves under Kennedy as National Institutes of Health director. Kulldorff wrote a 29-page report on Gardasil that was filed on January 6 in the North Carolina case. His conclusion was that Merck had "not done an appropriate job evaluating potential safety problems" related to the shot. He also highlighted his prior service on ACIP's vaccine safety working groups. Gardasil was approved in the U.S. in 2006 after going through clinical trials to prove its safety and efficacy. "I have served on two CDC ACIP vaccine safety working groups, concerning the measles-mumps-rubella-varicella (MMRV) and COVID vaccines," Kulldorff wrote. He also wrote in his litigation report that he developed some of the methods that are used "by FDA and CDC in their routine post-market vaccine safety surveillance work." REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you.

Vaccine demand in Malaysia rises amid regional surge in Covid-19 cases
Vaccine demand in Malaysia rises amid regional surge in Covid-19 cases

Straits Times

time2 days ago

  • Straits Times

Vaccine demand in Malaysia rises amid regional surge in Covid-19 cases

The revived interest is given the rising numbers of the new variant of Covid-19 in Thailand and Singapore. PHOTO: REUTERS GEORGE TOWN, Malaysia - Medical practitioners are seeing a renewed interest in vaccination and booster shots, particularly among vulnerable populations, amid a concerning surge in Covid-19 cases in neighbouring countries. General practitioner Dr Parmjit Singh said the revived interest is in response to locals being highly vigilant given the rising numbers of the new variant of Covid-19 in Thailand and Singapore. 'It is essential for eligible indivi­duals to be up to date with their vaccinations to maintain strong protection, especially against emerging variants,' he said here on June 11. He also said that while the Covid-19 situation in the country may appear stable, it has not been eradicated. 'Malaysians are encouraged to stay up to date with vaccinations, practise good hygiene, wear masks in crowded or enclosed spaces and seek medical attention if symptoms develop. 'Continued public awareness and responsible behaviour are key to preventing another surge in cases. 'New variants may spread across borders through travel and community interactions,' he said. Dr Parmjit also said that there is no definitive evidence that dry weather can cause a spike in Covid-19 cases. 'Weather changes can influen­ce human behaviour. People may spend more time indoors in air-conditioned spaces during hot, dry seasons, which could increase the risk of virus transmission. 'The spread of the virus is dependent on factors such as popu­lation density, vaccination coverage, public health measures and individual behaviour,' he said. Penang health committee chairman Daniel Gooi said Penang experienced notable spikes during major holidays or festive periods due to increased travel, relaxed precautions and social gatherings. 'While there is no evidence that dry weather increases Covid-19 transmission, in Malaysia, hot and dry conditions may lead to more indoor gatherings. This could facilitate virus spread,' he said. It was reported that neighbou­ring countries like Thailand and Singapore are facing an emergence of subvariants derived from the Omicron strain of Covid-19, which are more contagious, leading to a surge in cases. Mr Gooi said while cases have dropped in Penang, it is important to remain vigilant as records from Jan 1 to May 31 last year showed 2,714 cases, while 1,594 cases were recorded during the same period this year. 'No deaths have been recorded so far this year, and the state Health Department continues to monitor respiratory-related clusters in Penang. 'High-risk groups (the elderly and persons with chronic illnesses) are advised to avoid crowded indoor areas. 'The vulnerable groups (elderly, comorbidities) are still encou­raged to get updated boosters as they can help protect them in case of exposure to those with Covid-19,' he said. Retired teacher B. Premala, 68, who has been vaccinated and took one booster jab in 2021 as well, said she was not keen on taking a fourth jab. 'I am careful and mask up when I go to crowded places. 'I am aware that because of my age, I am susceptible to viruses, but I am cautious,' she said. THE STAR/ ASIA NEWS NETWORK Join ST's Telegram channel and get the latest breaking news delivered to you.

Kennedy replaces fired US CDC panel members, includes anti-vaccine proponents
Kennedy replaces fired US CDC panel members, includes anti-vaccine proponents

Straits Times

time2 days ago

  • Straits Times

Kennedy replaces fired US CDC panel members, includes anti-vaccine proponents

US Health Secretary Robert Kennedy Jr alleged that the prior panel members had conflicts of interest. PHOTO: REUTERS WASHINGTON - US Health Secretary Robert Kennedy Jr named eight members to serve on a key panel of vaccine advisers on June 11, including several who have advocated against vaccines, after abruptly firing all 17 members of the independent committee of experts. They will sit on the US Centres for Disease Control and Prevention's Advisory Committee for Immunisation Practices, which advises the agency on who should get the shots after they are approved by the US Food and Drug Administration. The group of eight - the minimum number allowed by the ACIP founding charter - includes four who have previously worked on committees associated with either the CDC, the Food and Drug Administration, or both. Others have published papers, posted on social media, or written online biographies with anti-vaccine views, including against the mRNA vaccine technology used in some of the newest immunizations such as the Covid-19 vaccine. Among them is Mr Robert Malone, one of the most prominent voices opposing mRNA vaccines. He is aligned with Mr Kennedy's Make America Healthy Again movement. The group also includes Mr Joseph Hibbeln, Mr Martin Kulldorff, Mr Retsef Levi, Mr Cody Meissner, Mr James Pagano, Mr Vicky Pebsworth and Mr Michael Ross. Mr Kennedy, who has long questioned the safety of vaccines contrary to scientific evidence, alleged that the prior panel members, many of whom were appointed by President Joe Biden, had conflicts of interest, without providing evidence of specific members' conflicts. He said the move was necessary 'to re-establish public confidence in vaccine science'. Committee members said their ACIP work follows rigorous vetting of their financial ties and that they must abstain from votes on any vaccine for which they have a conflict. Mr Kennedy said on X that the panel would attend the committee's June 25 meeting. Advisers had been expected to deliberate and vote on who should receive a number of vaccines, including the flu shot and 2025-26 Covid-19 vaccine boosters, and the meeting had been slated for June 25-27. No agenda has been published yet. Shares of vaccine makers Moderna and Pfizer, which both produced mRNA Covid vaccines, fell marginally while those of Novavax, which did not utilise mRNA in its vaccine, rose marginally in after-hours trading. New members It is unclear how new members of the panel have been vetted for conflicts of interest, or when the vetting process began. Mr Meissner and Mr Pebsworth have served on the FDA's Vaccines and Related Biological Products Advisory Committee, and Mr Meissner also previously served on ACIP. Mr Pebsworth is now associated with the National Vaccine Information Centre, a group that advocates for vaccine exemptions and educates about vaccine injury. Mr Kulldorff is an architect of the Great Barrington Declaration, which called for a lighter public health response to Covid-19 in October 2020, and previously served on an ACIP vaccine safety subgroup. Mr Levi has in the past said mRNA vaccines can cause serious harm and death, especially among children, and called for their immediate withdrawal. Mr Ross, a professor at George Washington University, is an operating partner of Havencrest Capital Management, a firm focused on healthcare investments, according to its website. The FDA has found that the mRNA Covid-19 vaccines are generally safe and effective, but Commissioner Marty Makary has questioned the benefit of repeated annual shots for healthy, younger Americans. REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store